NSE - Free Realtime Quote INR
Lincoln Pharmaceuticals Limited (LINCOLN.NS)
As of 2:49 PM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
632,172.00
392,619.00
761,319.00
692,695.00
Investing Cash Flow
--
-573,416.00
-366,426.00
-780,802.00
-642,273.00
Financing Cash Flow
--
-51,804.00
-45,013.00
-25,561.00
-57,453.00
End Cash Position
--
57,472.00
50,520.00
69,340.00
114,383.00
Capital Expenditure
--
-396,130.00
-142,820.00
-455,252.00
-87,503.00
Issuance of Debt
--
200,000.00
193,574.00
20,000.00
--
Repayment of Debt
--
-209,019.00
-195,018.00
-5,197.00
-45,543.00
Free Cash Flow
--
236,042.00
249,799.00
306,067.00
605,192.00
3/31/2021 - 12/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INDOCO.NS Indoco Remedies Limited
314.50
+0.72%
INNOVACAP.NS Innova Captab Limited
843.65
+2.73%
GUFICBIO.NS Gufic Biosciences Limited
473.20
+1.17%
BLISSGVS.NS Bliss GVS Pharma Limited
129.29
+4.70%
IOLCP.NS IOL Chemicals and Pharmaceuticals Limited
410.40
+3.41%
CAPLIPOINT.NS Caplin Point Laboratories Limited
2,055.00
+1.65%
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,304.10
+2.51%